English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood
Tag: Mount Sinai Health System
HealthQuarters and Mount Sinai Health System Promise to Deliver Curated, Comprehensive Health and Wellness Experience
HealthQuarters today announces a new venture with Mount Sinai Health System to expand access to world-class health care services.
MEDIA ADVISORY- Back to School, Cold & Flu Season and COVID-19 – What do you do if you get sick?
Mount Sinai experts say get your flu shot early and have a plan for point-of-care
Mount Sinai Doctors Opens New Comprehensive Location in Scarsdale, New York
Mount Sinai Doctors has opened a new location in Scarsdale, New York, that includes a team of highly skilled physicians and nurses, and services that include primary care, cardiology, gastroenterology, orthopedics, gynecology, and many others. The new, state-of-the-art facility is 15,000 square feet and located at 341 Central Park Avenue, Scarsdale, NY.
Mount Sinai Named As 2020 National LGBTQ Health Equity Leader
Seven hospitals within the Mount Sinai Health System have been recognized as national leaders in LGBTQ health care equality by the Human Rights Campaign Foundation’s 2020 Healthcare Equality Index (HEI).
Mount Sinai’s Cardiac Catheterization Labs Given Highest Safety Ratings in New York State
Mount Sinai cardiologist also ranked No. 1 for safety in percutaneous coronary interventions
Mount Sinai Health System Hospitals Receive Top Quality Achievement Awards for Stroke and Cardiac Care
Mount Sinai Health System Hospitals Receive Top Quality Achievement Awards for Stroke and Cardiac Care
Mount Sinai Serves as Official Medical Services Provider and Advisor on COVID-19 Safety for Athletes at 2020 US Open
Mount Sinai will serve as the official medical services provider for the eighth consecutive year at the US Open
Researchers Discover a Specific Brain Circuit Damaged by Social Isolation During Childhood
Study shows long-lasting effects and points the way to potential treatments
Mount Sinai Team Offers Additional Data on Efficacy of Blood Thinners for COVID-19 and Insight on Best Potential Regimens
Study is the basis of a new international clinical trial
Mount Sinai Study Finds COVID Patients Were Most Commonly Readmitted to Hospital for Respiratory Complications
Study describes characteristics of patients with COVID-19 who returned to the ER or required readmission to the hospital within 14 days of being discharged
Dilated Blood Vessels in the Lung May Explain Low Oxygen Levels in Severe Cases of COVID-19
A new pilot study from the Icahn School of Medicine at Mount Sinai suggests that COVID-19 is causing significant dilation of the blood vessels of the lung, specifically the capillaries.
New Study Identifies Better Treatment Option for Common Complication of Dialysis
Use of drug-coated balloon angioplasty to treat blocked blood vessels used for hemodialysis offers hope for millions of patients globally
Mount Sinai Cardiologists First on East Coast to Offer New Stroke Prevention Therapy for Heart Patients
New generation implant has improved safety and performance features for those with atrial fibrillation
New York Eye and Ear Infirmary of Mount Sinai Celebrates 200th Anniversary and Honors its Pioneering Black Physician
Hosts Dedication for a Former Slave Who Became Country’s First African American Eye and Ear Specialist
Mount Sinai’s Arnhold Institute for Global Health Partners with NYC Health + Hospitals on COVID-19 Unit for Research at Elmhurst (CURE-19)
Collaboration Brings Together Clinicians and Researchers on the Front Lines of COVID-19 to Support Innovative Solutions for Health Disparities
Epigenetic Changes in ADNP Syndrome, a Cause of Autism, Do Not Indicate Profound Presentation of the Disorder
A study led by the Seaver Autism Center for Research and Treatment at Mount Sinai found that two different blood epigenetic signatures associated with ADNP syndrome (also known as Helsmoortel-Van Der Aa syndrome) have only a modest correlation with clinical manifestations of the syndrome.
Mount Sinai Medical Legal Partnership Names Executive Director
The Mount Sinai Medical Legal Partnership (MSMLP) has appointed Allison Charney as its Executive Director. Ms. Charney was a founding member of the MSMLP and has been Co-Chair of the Board of Directors since its inception in 2014.
Mount Sinai Researchers Discover Treatment Option for Rare Genetic Disorder
Researchers from the Icahn School of Medicine used a novel genetic sequencing technology to identify the genetic cause of—and a treatment for—a previously unknown severe auto inflammatory syndrome affecting an 18-year-old girl since infancy.
The Mount Sinai Hospital Ranked Among Top in the Nation by U.S. News & World Report; Brookdale Department of Geriatrics and Palliative Medicine Claims No. 1 Spot in Specialty Rankings
The Mount Sinai Hospital, the flagship hospital of Mount Sinai Health System, was listed among the nation’s top hospitals for care excellence in U.S. News and World Report, marking the fifth straight year the hospital has been listed among the top 20 in the country while landing on the distinctive “Honor Roll” list.
SARS-CoV-2 is More Severe in Men, Emerging Data Suggests in New Review by Mount Sinai Researchers
Senior Author: Ash Tewari, MBBS, MCh, Chair of the Department of Urology at the Mount Sinai Health System, Professor, Urology, Oncological Sciences, Icahn School of Medicine at Mount Sinai First Author: Dimple Chakravarty, PhD, Assistant Professor, Urology, Icahn School of Medicine…
Mount Sinai study finds SARS-CoV-2 induces robust antibody responses stable for at least 3 months
Research from the Mount Sinai Health System, just posted to pre-print server MedRxiv (https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1), shows that the vast majority (more than 90%) of infected individuals with mild-to-moderate COVID 19 experience robust IgG antibody responses against the viral spike protein. The researchers also show…
Low-Carbohydrate Diet May Be Associated With Lower Risk of Blinding Eye Disease
Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma
OMRON Healthcare and Mount Sinai Health System Collaborate to Help High-Risk Patients Monitor Their Blood Pressure from Home with VitalSight
• Ensures close connection between patient and physician for remote hypertension monitoring
• Complements Mount Sinai’s growing telehealth initiative
• Medicare-covered and generally at no cost to patients, depending on coverage
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding
Mount Sinai and Emergent to conduct clinical trials to evaluate COVID-HIG for post-exposure prophylaxis of COVID-19 in front-line health care workers and to support a potential Expanded Access Program for military personnel with funding from the U.S. Department of Defense
– ImmunoTek to extend operating license and provide training to Mount Sinai to establish onsite plasma collection to support production of COVID-HIG
Mount Sinai Health System and Richmond University Medical Center Announce Expanded Clinical and Academic Affiliation to Broaden Access to World-Class Care to Staten Island Residents
Affiliation will include newly formed comprehensive cancer program, co-branded emergency
department, and integrated internal medicine and specialty physician practices
Mount Sinai Researchers Find That COVID-19 Patients with HIV Did Not Experience Poorer Outcomes
Patients with HIV who were hospitalized with COVID-19 did not experience poorer outcomes compared to a similar comparison group of patients.
Researchers Identify Distinct Subtypes of Polycystic Ovary Syndrome With Novel Genetic Associations
Mount Sinai researchers have for the first time identified reproductive and metabolic subtypes of polycystic ovary syndrome (PCOS) that are associated with novel gene regions.
Mount Sinai seeks EUA from Food and Drug Administration for potential quantitative serologic test for COVID-19
If authorized for quantitative use, the assay could be used to provide a numeric result for the concentration of neutralizing anti-COVID-19 antibodies in plasma.
Mount Sinai Health System Appoints Beth Oliver, DNP, RN, as Senior Vice President and Chief Nursing Executive
Mount Sinai Health System has appointed Beth Oliver, DNP, RN, to the role of Senior Vice President and Chief Nursing Executive.
Mount Sinai Health System Appoints Kristin Myers, MPH, as Executive Vice President, Chief Information Officer, and Dean for Information Technology
Mount Sinai Health System has appointed Kristin Myers, MPH, as Executive Vice President, Chief Information Officer, and Dean for Information Technology.
Two Widely-Used Drugs for Erectile Dysfunction Could Be Repurposed to Treat Osteoporosis
Why the Research Is Interesting: Osteoporosis is a global public health problem that affects almost 200 million people worldwide. Erectile dysfunction is the most common male sexual dysfunction in the aging population, with more than 70% of men over the…
Heart Injury Among Hospitalized COVID-19 Patients Associated with Higher Risk of Death
Study findings may help doctors better triage coronavirus patients admitted to the hospital
Mount Sinai Receives Microsoft AI for Health Grant to Support Center Dedicated to Data Science Discovery for COVID-19
Grant Will Enable Development of AI Tools to Enhance Care and Evidence-based Medicine for Treating COVID-19 Patients
Discovery in Acute Myeloid Leukemia Could Provide Novel Pathway for New Treatments
Researchers at Mount Sinai have discovered that human acute myeloid leukemia (AML) stem cells are dependent on a transcription factor known as RUNX1, potentially providing a new therapeutic target to achieve lasting remissions or even cures for a disease in which medical advances have been limited.
Researchers Identify Mechanisms That Make Skin a Protective Barrier
Study Could Help Doctors Understand and Treat Common Conditions
#FitForTheFrontLine Challenge Unites Nation’s Top Medical Centers in Support of Front-Line Health Care Workers
Fitness challenge honors and supports health care heroes at Mount Sinai Health System and Academic Centers Across the Country. Goldman Sachs & Co., Peloton, Discovery, NBCUniversal Owned Television Stations, dtx and Pinterest Support First-Ever Collective Medical Center Campaign.
Mount Sinai Health System and Renalytix Form Joint Venture, Kantaro Biosciences, To Develop and Scale Production of COVID Antibody Test Kits
– Kantaro Biosciences partners with Bio-Techne for manufacturing and global kit distribution
– Scaled kit production to enable clinical laboratories to conduct 10M tests per month is planned to begin in July
Mount Sinai First in U.S. to Use Artificial Intelligence to Analyze Coronavirus (COVID-19) Patients
Mount Sinai researchers are the first in the country to use artificial intelligence (AI) combined with imaging, and clinical data to analyze patients with coronavirus disease (COVID-19).
Mount Sinai Launches New Institute for Health Equity Research
COVID-19 Crisis Spurs Institute to Understand and Combat Health Disparities in Underserved Communities. Earvin “Magic” Johnson, five-time NBA champion, and New York State Senator Brian Benjamin Among Industry and Public Health Leaders to Join Institute Task Force.
Mount Sinai Announces First-of-its-Kind Center For Post-COVID Care
Center to provide post-multidisciplinary care and psychosocial resources for patients recovering from pandemic disease
COVID-19 Registry and clinical trials component will define new standards of care for patients
Artificial Intelligence Algorithm Can Rapidly Detect Severity of Common Blinding Eye Disease
A new artificial intelligence (AI) algorithm developed by researchers at New York Eye and Ear Infirmary of Mount Sinai (NYEE) can rapidly and accurately detect age-related macular degeneration (AMD), a leading cause of vision loss in the United States.
Insulin Resistance Contributes to Racial Disparities in Breast Cancer Prognosis in U.S. Women, Mount Sinai Researchers Reveal
New study identifies that differences in insulin resistance can explain in part the disparities in breast cancer survival between black and white women
Mount Sinai Works With Google Nest to Help Patients With COVID-19
A New Nest Camera Console Enhances Safety of Patients and Staff; Reduces PPE Demands
Blood Thinners may Improve Survival among Hospitalized COVID-19 Patients
Research could change standard of care protocols to prevent clotting associated with coronavirus
Neighborhood Racial and Economic Polarization, Hospital of Delivery, and Severe Maternal Morbidity
How neighborhood racial and economic spatial polarization, an extreme form of residential segregation, influences maternal health.
Mount Sinai Announces Center for Stress, Resilience and Personal Growth
Center will address psychosocial impact of COVID-19 among frontline health workers; Focus is on screening, treatment, and research
Mount Sinai Researchers Collaborate with GenScript to Develop a COVID-19 Antibody to Treat Sick Patients
The highly targeted antibody may block the coronaviruses’ ability to enter human lung cells
Raising Mount Sinai
The musicians of Carnegie Hall, featuring a song and words of support by Jimmy Buffet and others join forces to raise money for the front-line health care staff at the Mount Sinai Health System
Mount Sinai’s Blood Test to Detect Antibodies to COVID-19 Receives Emergency Use Authorization From U.S. Food and Drug Administration
Today, the Mount Sinai Laboratory (MSL), Center for Clinical Laboratories received emergency use authorization from the U.S. Food and Drug Administration (FDA) for an antibody test that was developed, validated, and launched at Mount Sinai by a team of internationally renowned researchers and clinicians of the Icahn School of Medicine at Mount Sinai. This test detects the presence or absence of antibodies to SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19) and importantly, may also be used to identify positive specimens with an antibody titer (level) up to a dilution of 1:2880 for the identification of individuals with higher antibody titers.